Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
Stockholm - Delayed Quote SEK

CHOSA Oncology AB (CHOSA.ST)

Compare
0.9000
+0.2000
+(28.57%)
At close: 3:09:43 PM GMT+1
Currency in SEK All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Expense
7,732
23,512
1,167
61,856.7040
47,467.7060
Operating Income
-7,732
-23,512
-1,167
-61,856.7040
-47,467.7060
Net Non Operating Interest Income Expense
-459.6460
-512.6460
--
-204.0620
-428.6640
Pretax Income
-7,920
-23,752
-1,167
-62,076.5550
-47,935.7640
Tax Provision
191
191
-146
-7,502.5280
-7,744.0930
Net Income Common Stockholders
-8,111
-23,943
-1,021
-54,574.0270
-40,191.6710
Diluted NI Available to Com Stockholders
-8,111
-23,943
-1,021
-54,574.0270
-40,191.6710
Basic EPS
-0.12
-0.37
-0.05
-2.87
-2.11
Diluted EPS
-0.12
-0.37
-0.05
-2.87
-2.11
Basic Average Shares
64,873.9130
62,030.9830
19,047.1020
19,047.1020
19,047.1020
Diluted Average Shares
64,873.9130
62,030.9830
19,047.1020
19,047.1020
19,047.1020
Total Operating Income as Reported
-7,733
-23,512
-1,167
-61,856.7040
-47,467.7060
Total Expenses
7,732
23,512
1,167
61,856.7040
47,467.7060
Net Income from Continuing & Discontinued Operation
-8,111
-23,943
-1,021
-54,574.0270
-40,191.6710
Normalized Income
-8,111
-23,943
-1,021
-54,574.0270
-40,191.6710
Interest Income
-238.0740
1.9260
--
--
--
Interest Expense
221.5720
514.5720
--
204.0620
428.6640
Net Interest Income
-459.6460
-512.6460
--
-204.0620
-428.6640
EBIT
-7,698.4280
-23,237.4280
-1,167
-61,872.4930
-47,507.1000
EBITDA
-7,698.4280
-22,467.4280
-667
-61,872.4930
-47,507.1000
Reconciled Depreciation
--
770
500
--
--
Net Income from Continuing Operation Net Minority Interest
-8,111
-23,943
-1,021
-54,574.0270
-40,191.6710
Normalized EBITDA
-7,698.4280
-22,467.4280
-667
-61,872.4930
-47,507.1000
Tax Rate for Calcs
0.0002
0.0002
0.0001
0.0001
0.0002
12/31/2020 - 3/9/2016

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

MAGLE.ST Magle Chemoswed Holding AB (publ)
32.40
0.00%
 
NV3P.F NanoViricides, Inc.
1.1300
-11.72%
 
MOC.WA Molecure S.A.
9.00
+1.69%
 
RGO.DU Regeneron Pharmaceuticals Inc
684.00
+1.33%
 
HQ1.MU Oruka Therapeutics Inc. R
10.30
-2.83%
 
BSSP Baseline Productions, Inc.
0.0001
0.00%
 
PH4.F CStone Pharmaceuticals
0.4320
+1.89%
 
GYX.F Futura Medical plc
0.1340
-25.56%
 
BXPHF Botanix Pharmaceuticals Limited
0.2950
0.00%
 
10VA.F Immunic, Inc.
1.1000
-1.79%